Equitec Proprietary Markets’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,600
Closed -$424 95
2023
Q4
$424 Hold
10,600
﹤0.01% 91
2023
Q3
$161 Sell
10,600
-24,400
-70% -$839 ﹤0.01% 122
2023
Q2
$2.01K Sell
35,000
-32,200
-48% -$1.95K ﹤0.01% 88
2023
Q1
$4.03K Sell
67,200
-124,220
-65% -$10.3K ﹤0.01% 104
2022
Q4
$12.6K Sell
191,420
-800
-0.4% -$175 ﹤0.01% 129
2022
Q3
$74K Sell
192,220
-5,276
-3% -$2.29K 0.02% 130
2022
Q2
$114K Buy
197,496
+49,993
+34% +$49.3K 0.03% 121
2022
Q1
$202K Sell
147,503
-52,314
-26% -$42.6K 0.04% 85
2021
Q4
$172K Buy
199,817
+66,375
+50% +$67.2K 0.02% 119
2021
Q3
$153K Buy
133,442
+73,442
+122% +$98.3K 0.03% 92
2021
Q2
$82K Buy
+60,000
New +$72K 0.02% 150

Other funds holding CELUW

Equitec Proprietary Markets's CELUW Position: Q1 2024 in Review

Equitec Proprietary Markets sold out of Celularity Inc (CELUW) in Q1 2024, closing a stake of 10,600 shares — an estimated $424 sold.

Equitec Proprietary Markets first reported a position in CELUW in Q2 2021 and held it in 11 quarters. The position peaked at $202K in Q1 2022. 12 funds tracked by Wall St. Rank hold CELUW as of Q1 2024.

  • Equitec Proprietary Markets reported no remaining Celularity Inc position as of Q1 2024 after selling out during the quarter.
  • Equitec Proprietary Markets sold 10,600 Celularity Inc shares in Q1 2024, an estimated $424.
  • Equitec Proprietary Markets first reported a position in Celularity Inc in Q2 2021 and held it in 11 quarters.
  • Equitec Proprietary Markets's Celularity Inc position peaked at $202K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2024.

Based on Equitec Proprietary Markets's 13F filing for Q1 2024, filed 26 Apr 2024.